Iranian Journal of Psychiatry 2016. 11(4):234-238.

The Effects of Sertraline in Controlling Refractory Hypertension in Women with Premenstrual Syndrome
Fatemeh Ranjbar, Fariborz Akbarzadeh, Mahboub Asadlou


Objective: The aim of this study was to evaluate the effect of Premenstrual Syndrome (PMS) treatment with selective serotonin reuptake inhibitor (SSRI) on treatment response of refractory hypertension of the patients.

Method: This was a triple-blind randomized clinical trial conducted on female patients suffering from refractory hypertension and PMS at the same time. We obtained informed consent from 40 patients who had inclusion criteria and selected 20 patients for the intervention (sertraline 50 mg daily) and 20 for the control groups. The study period was five weeks. The mean of systolic and diastolic blood pressure before and after intervention was measured separately for each individual in each group and the mean of blood pressure of the members of the two groups were compared with each other.

Results: The mean age of the participants was 43.60 ± 4.57. In this study, systolic and diastolic blood pressure of both groups reduced after intervention. The mean of systolic blood pressure was reduced by 40.86 mmHg in the intervention group and this reduction was 16 mm Hg in control group after intervention (P<0.001). Comparing this reduction between the two groups, we found that reduction rate in systolic blood pressure of the two groups did not have a significant statistical difference before and after the intervention (P = 0.11). Mean of diastolic blood pressure also showed reduction of 9.17 mm Hg and that of control group showed 6.7-mmHg reduction. Reduction rate of diastolic blood pressure in the intervention group had a statistically significant difference with that of the control group (P<0.017).‎‎

Conclusion: Administration of sertraline is more effective in controlling diastolic blood pressure in women suffering from refractory hypertension and comorbid PMS.


Premenstrual Syndrome, Refractory Hypertension, Sertraline

Full Text:



Endicott J. History, evolution, and diagnosis of premenstrual dysphoric disorder. J Clin Psychiatry 2000; 61 Suppl 12: 5-8.

Sadock BJ. Kaplan & Sadock's Comprehensive Textbook of Psychiatry (2 Volume Set): Lippincott Williams & Wilkins; 2000.

Matsumoto T, Ushiroyama T, Kimura T, Hayashi T, Moritani T. Altered autonomic nervous system activity as a potential etiological factor of premenstrual syndrome and premenstrual dysphoric disorder. Biopsychosoc Med 2007; 1: 24.

First MB. Diagnostic and statistical manual of mental disorders. DSM IV-4th edition APA p. 1994:97-327.

Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt) 2006; 15: 57-69.

Metzl JM, Angel J. Assessing the impact of SSRI antidepressants on popular notions of women's depressive illness. Soc Sci Med 2004; 58: 577-584.

Shah NR, Jones JB, Aperi J, Shemtov R, Karne A, Borenstein J. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol 2008; 111: 1175-1182.

Ghojazadeh M, Naghavi-Behzad M, Nasrolah-Zadeh R, Bayat-Khajeh P, Piri R, Mirnia K, et al. Knowledge production status of Iranian researchers in the gastric cancer area: based on the medline database. Asian Pac J Cancer Prev 2014; 15: 5083-5088.

Maleki D, Ghojazadeh M, Mahmoudi SS, Mahmoudi SM, Pournaghi-Azar F, Torab A, et al. Epidemiology of Oral Cancer in Iran: a Systematic Review. Asian Pac J Cancer Prev 2015; 16: 5427-5432.

Steiner M. Recognition of premenstrual dysphoric disorder and its treatment. The Lancet 2000; 356: 1126-1127.

Okeahialam BN. Refractory hypertension in women controlled after identifying and addressing premenstrual syndrome. J Natl Med Assoc 2004; 96: 1422-1423.

Okeahialam BN, Obindo JT, Ogbonna C. Prevalence of premenstrual syndrome and its relationship with blood pressure in young adult females. Afr J Med Med Sci 2008; 37: 361-367.

Matsumoto T, Ushiroyama T, Morimura M, Moritani T, Hayashi T, Suzuki T, et al. Autonomic nervous system activity in the late luteal phase of eumenorrheic women with premenstrual symptomatology. J Psychosom Obstet Gynaecol 2006; 27: 131-139.

Aliasgarzadeh A, Ghojazadeh M, Haji-Hoseini R, Mehanfar F, Piri R, Naghavi-Behzad M, et al. Age related secretary pattern of growth hormone, insulin-like growth factor-I & insulin-like growth factor binding protein-3 in postmenopausal women. Indian J Med Res 2014; 139: 598-602.

Baker FC, Colrain IM, Trinder J. Reduced parasympathetic activity during sleep in the symptomatic phase of severe premenstrual syndrome. J Psychosom Res 2008; 65: 13-22.

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-2219.

Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health 2006; 9: 41-49.

Fauci AS. Harrison's principles of internal medicine: McGraw-Hill Medical New York; 2008.

Dvivedi J, Kaur H, Dvivedi S. Effect of 1 week '61-points relaxation training' on cold pressor test induced stress in premenstrual syndrome. Indian J Physiol Pharmacol 2008; 52: 262-266.

Klatzkin RR, Lindgren ME, Forneris CA, Girdler SS. Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences. Biol Psychol 2010; 84: 235-247.

Gordon JL, Girdler SS. Mechanisms underlying hemodynamic and neuroendocrine stress reactivity at different phases of the menstrual cycle. Psychophysiology 2014; 51: 309-318.

Minson CT, Halliwill JR, Young TM, Joyner MJ. Influence of the menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation 2000; 101: 862-868.

Hirshoren N, Tzoran I, Makrienko I, Edoute Y, Plawner MM, Itskovitz-Eldor J, et al. Menstrual cycle effects on the neurohumoral and autonomic nervous systems regulating the cardiovascular system. J Clin Endocrinol Metab 2002; 87: 1569-1575.

Kanojia S, Sharma VK, Gandhi A, Kapoor R, Kukreja A, Subramanian SK. Effect of yoga on autonomic functions and psychological status during both phases of menstrual cycle in young healthy females. J Clin Diagn Res 2013; 7: 2133-2139.

Yildirir A, Kabakci G, Akgul E, Tokgozoglu L, Oto A. Effects of menstrual cycle on cardiac autonomic innervation as assessed by heart rate variability. Ann Noninvasive Electrocardiol 2002; 7: 60-63.

Fakhrjou A, Dastranj-Tabrizi A, Ghojazadeh M, Ghorashi S, Velayati A, Piri R, et al. Diagnostic Value of Protein Ki67 (MIB-1) in Atypical Pap Smears of Postmenopausal Women. Asian Pacific Journal of Cancer Prevention. 2013;14(8):4815-8.

Anand NS. A Cross-Sectional Study To Assess The Cardio-Respiratory, Autonomic And Psychosomatic Responses And Responses To Graded Exercise Protocol During Different Phases Of Menstrual Cycle Among Mbbs Phase-I Students: KLE University, Belgaum, Karnataka; 2013.

Schatzberg AF, Nemeroff CB. The American psychiatric publishing textbook of psychopharmacology: American Psychiatric Pub; 2009.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.